Skip to main content

Translational Research in Clinical Oncology

Recent advances in understanding cancer biology are beginning to be translated into improvements in diagnosis and treatment of cancer. In the post-genome era, we increasingly rely on strong collaboration between basic and clinical scientists to develop novel approaches for treatment of human disease. The Center for Cancer Research (CCR) of the NCI is one of the largest centers for cancer research in the world, with over 200 Principal Investigators, and has a major role in development and implementation of many of new technologies, such as nanotechnology, next generation sequencing, genomics and proteomics.

The Translational Research in Clinical Oncology (TRACO) course is usually held on Monday afternoons from September to November by WebEx. TRACO is designed to provide an overview of general principles of cancer biology and treatment, epidemiology, genomics, precision medicine, mechanisms of resistance, use of preclinical models, and identification of novel molecular targets. Participants will have an unprecedented opportunity to learn new information, glimpse into future developments of translational research in clinical oncology and meet leaders in cancer research. The participation of NIH Postdoctoral and Clinical Fellows is encouraged.

Registration

The 2020 TRACO registration is now CLOSED.

For more information contact Dr. Terry Moody at moodyt@mail.nih.gov or by phone at 240-276-7785.

Certificate

Participants who registered for the course, may receive a certificate of completion after attending the lectures and passing the TRACO examination.  

Location and Time

Two hour sessions will usually occur on Mondays, 4-6 p.m by WebEx.  In addition lectures will be videocast and archived. Each session will have two 50-min lectures in Basic and Clinical Sciences with ample time for discussion and analysis. A handout for each lecture will be distributed on site. Classes will occur from Sept. 8, 2020 to Nov. 30, 2020.   

Faculty Coordinators

  • Irwin Arias, M.D.
  • Terry Moody, Ph.D.
  • Lyuba Varticovski, M.D.
  • Farah Zia, M.D.
  • Oliver Bogler, Ph.D.

Faculty

  • C. Annunziata, M.D.
  • S. Goff, M.D.
  • N. Caporaso, M.D.
  • P. Choyke, M.D.
  • H. Chen, M.D.
  • M. Dobrovolskaia, Ph.D.
  • C. Harris, M.D.
  • P. Hussain, Ph.D. 
  • S. Jakowlew, Ph.D.
  • J. Luo, Ph.D.
  • L. Mikkelneni, M.D.
  • E. Nichols, M.D. 
  • J. Del Reviro, M.D.
  • R. Madan, M.D.
  • F. Maldarelli, M.D.
  • T. Moody, Ph.D.
  • O. Olaku, M.D.
  • Y. Pommier, M.D.
  • J. Schiller, Ph.D.
  • E. Szabo, M.D.
  • J. Smith, M.D.
  • B. Ryan, Ph.D.
  • A. Simeonov, Ph.D.
  • M. Verma, Ph.D.
  • J. Wei, Ph.D.
  • F. Zia, M.D.
TRACO Course Schedule
Date Topics Faculty
Sept. 8

Introduction

Cervical cancer

T. Moody

J. Schiller

Sept. 14

Cancer disparities

Immune checkpoints

B. Ryan

S. Goff

Sept. 21

Ovarian cancer 

TGFβ

C. Annunziata

S. Jakowlew

Sept. 28

Clinical trials

Small Molecules   

J. Smith

A. Simeonov 

Oct. 8

Radiation oncology

CAR-T cells

E. Nichols

L. Mikkelneni

Oct. 15

Prostate cancer 

Tumor imaging  

R. Madan

P. Choyke

Oct. 19

Genomics 

Epidemiology

 J. Wei

N. Caporaso

Oct. 26

Breast Cancer 

HIV

F Zia

F. Maldarelli

Nov. 2

K-RAS

SCLC

J. Luo

H. Chen

Nov. 9

NSCLC

Case Reports

E. Szabo

O. Olaku

Nov. 16

Epigenetics

Brain Cancer

M. Verma

Timmer

Nov. 23

Precision medicine

Topoisomerase

C. Harris

Y. Pommier

Nov. 30

Pancreatic cancer

Nanotechnology

P. Hussain

M. Dobrovolskaia

  • Updated: